| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Mar 13, 2024 | Sale | $162.16 | 8,891 | 1,441,765 | 15,043 | Mar 13, 2024, 04:36 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2024 | Option Exercise | $157.85 | 333 | 52,564 | 82,266 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Feb 13, 2024 | Option Exercise | $157.85 | 773 | 122,018 | 68,890 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 13, 2024 | Option Exercise | $157.85 | 666 | 105,128 | 154,851 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | Feb 13, 2024 | Option Exercise | $157.85 | 195 | 30,781 | 14,570 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Feb 13, 2024 | Option Exercise | $157.85 | 250 | 39,463 | 13,040 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Feb 13, 2024 | Option Exercise | $157.85 | 474 | 74,821 | 112,076 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Feb 13, 2024 | Option Exercise | $157.85 | 427 | 67,402 | 38,647 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Feb 13, 2024 | Option Exercise | $157.85 | 1,507 | 237,880 | 363,302 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 13, 2024 | Option Exercise | $157.85 | 209 | 32,991 | 23,934 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | Feb 13, 2024 | Option Exercise | $157.85 | 236 | 37,253 | 8,340 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Feb 13, 2024 | Option Exercise | $157.85 | 86 | 13,575 | 18,973 | Feb 15, 2024, 04:53 PM | |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 12, 2024 | Option Exercise | $157.40 | 2,136 | 336,206 | 23,735 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Feb 12, 2024 | Option Exercise | $157.40 | 4,076 | 641,562 | 38,240 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Feb 12, 2024 | Option Exercise | $157.40 | 10,816 | 1,702,438 | 67,883 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | Feb 12, 2024 | Option Exercise | $157.40 | 1,034 | 162,752 | 7,925 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 12, 2024 | Option Exercise | $157.40 | 13,403 | 2,109,632 | 154,215 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Feb 12, 2024 | Option Exercise | $157.40 | 7,019 | 1,104,791 | 111,625 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | Feb 12, 2024 | Option Exercise | $157.40 | 1,695 | 266,793 | 14,318 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Feb 12, 2024 | Option Exercise | $157.40 | 15,900 | 2,502,660 | 361,339 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Feb 12, 2024 | Option Exercise | $157.40 | 2,887 | 454,414 | 12,791 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Feb 12, 2024 | Option Exercise | $157.40 | 523 | 82,320 | 18,746 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 12, 2024 | Option Exercise | $157.40 | 7,066 | 1,112,188 | 81,948 | Feb 14, 2024, 06:36 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 09, 2024 | Option Exercise | $119.23 | 62,971 | 7,507,822 | 102,534 | Feb 13, 2024, 05:18 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Feb 09, 2024 | Option Exercise | $118.93 | 229,631 | 27,311,091 | 439,283 | Feb 13, 2024, 05:18 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 08, 2024 | Option Exercise | $156.33 | 1,913 | 299,059 | 141,416 | Feb 12, 2024, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 09, 2024 | Sale | $123.36 | 118,794 | 14,653,834 | 200,813 | Feb 12, 2024, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Feb 08, 2024 | Option Exercise | $156.33 | 2,269 | 354,713 | 308,314 | Feb 12, 2024, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 08, 2024 | Option Exercise | $156.33 | 1,009 | 157,737 | 66,896 | Feb 12, 2024, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Feb 08, 2024 | Option Exercise | $156.33 | 1,047 | 163,678 | 52,864 | Feb 12, 2024, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | Feb 08, 2024 | Option Exercise | $156.33 | 363 | 56,748 | 6,100 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | Feb 08, 2024 | Option Exercise | $156.33 | 554 | 86,607 | 10,557 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Feb 08, 2024 | Option Exercise | $156.33 | 1,001 | 156,486 | 9,942 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Feb 08, 2024 | Option Exercise | $156.33 | 781 | 122,094 | 103,684 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Feb 08, 2024 | Option Exercise | $156.33 | 1,113 | 173,995 | 33,384 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 08, 2024 | Option Exercise | $156.33 | 703 | 109,900 | 20,380 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Feb 08, 2024 | Option Exercise | $156.33 | 215 | 33,611 | 17,357 | Feb 12, 2024, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Jul 25, 2023 | Sale | $170.32 | 20,000 | 3,406,498 | 102,696 | Jul 27, 2023, 05:52 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Jul 26, 2023 | Sale | $131.22 | 29,396 | 3,857,343 | 102,445 | Jul 27, 2023, 05:52 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Jun 12, 2023 | Sale | $160.00 | 12,465 | 1,994,400 | 65,934 | Jun 14, 2023, 04:19 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | Mar 06, 2023 | Sale | $154.66 | 1,062 | 164,249 | 9,215 | Mar 08, 2023, 04:16 PM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Feb 13, 2023 | Option Exercise | $162.01 | 8,578 | 1,389,722 | 50,397 | Feb 15, 2023, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2023 | Option Exercise | $162.01 | 4,891 | 792,391 | 78,399 | Feb 15, 2023, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 13, 2023 | Option Exercise | $162.01 | 10,569 | 1,712,284 | 139,590 | Feb 15, 2023, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | Feb 13, 2023 | Option Exercise | $162.01 | 918 | 148,725 | 10,277 | Feb 15, 2023, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Cons Health | Feb 13, 2023 | Option Exercise | $162.01 | 6,430 | 1,041,724 | 65,915 | Feb 15, 2023, 07:25 PM | |
| JNJ | JOHNSON & JOHNSON | McEvoy Ashley | EVP, WW Chair, MedTech | Feb 13, 2023 | Option Exercise | $162.01 | 7,158 | 1,159,668 | 54,825 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Feb 13, 2023 | Option Exercise | $162.01 | 4,586 | 742,978 | 87,747 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Feb 13, 2023 | Option Exercise | $162.01 | 5,765 | 933,988 | 122,696 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Feb 13, 2023 | Option Exercise | $162.01 | 13,599 | 2,203,174 | 316,393 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Feb 13, 2023 | Option Exercise | $162.01 | 397 | 64,318 | 16,917 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | Feb 13, 2023 | Option Exercise | $162.01 | 924 | 149,697 | 5,484 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 13, 2023 | Option Exercise | $162.01 | 1,440 | 233,294 | 19,203 | Feb 15, 2023, 07:24 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Feb 10, 2023 | Option Exercise | $162.08 | 2,267 | 367,435 | 298,673 | Feb 14, 2023, 04:37 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 10, 2023 | Option Exercise | $162.08 | 667 | 108,107 | 72,451 | Feb 14, 2023, 04:37 PM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Feb 10, 2023 | Option Exercise | $162.08 | 979 | 158,676 | 38,282 | Feb 14, 2023, 04:36 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 10, 2023 | Option Exercise | $162.08 | 1,289 | 208,921 | 128,737 | Feb 14, 2023, 04:36 PM | |
| JNJ | JOHNSON & JOHNSON | McEvoy Ashley | EVP, WW Chair, MedTech | Feb 10, 2023 | Option Exercise | $162.08 | 823 | 133,392 | 43,989 | Feb 14, 2023, 04:36 PM | |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | Feb 10, 2023 | Option Exercise | $162.08 | 380 | 61,590 | 3,853 | Feb 14, 2023, 04:35 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Feb 10, 2023 | Option Exercise | $162.08 | 1,399 | 226,750 | 82,693 | Feb 14, 2023, 04:35 PM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Cons Health | Feb 10, 2023 | Option Exercise | $162.08 | 826 | 133,878 | 58,635 | Feb 14, 2023, 04:35 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Feb 10, 2023 | Option Exercise | $162.08 | 191 | 30,957 | 15,863 | Feb 14, 2023, 04:35 PM | |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 10, 2023 | Option Exercise | $162.08 | 597 | 96,762 | 16,662 | Feb 14, 2023, 04:35 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Feb 10, 2023 | Option Exercise | $162.08 | 761 | 123,343 | 115,993 | Feb 14, 2023, 04:35 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | Feb 10, 2023 | Option Exercise | $162.08 | 388 | 62,887 | 7,967 | Feb 14, 2023, 04:34 PM | |
| JNJ | JOHNSON & JOHNSON | Gorsky Alex | Director | Jan 17, 2023 | Option Exercise | $112.99 | 914,302 | 103,310,748 | 1,133,194 | Jan 18, 2023, 04:39 PM | |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | Jan 17, 2023 | Option Exercise | $112.84 | 247,333 | 27,908,963 | 394,515 | Jan 18, 2023, 04:39 PM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Dec 13, 2022 | Sale | $133.90 | 29,562 | 3,958,250 | 50,593 | Dec 15, 2022, 04:34 PM | |
| JNJ | JOHNSON & JOHNSON | McEvoy Ashley | EVP, WW Chair, MedTech | Nov 30, 2022 | Sale | $124.00 | 146,646 | 18,184,629 | 115,136 | Dec 02, 2022, 04:32 PM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Nov 22, 2022 | Option Exercise | $124.66 | 153,846 | 19,178,366 | 203,379 | Nov 23, 2022, 04:44 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | Controller, CAO | Nov 18, 2022 | Option Exercise | $132.72 | 33,856 | 4,493,368 | 32,401 | Nov 21, 2022, 04:33 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief GSC Officer | Nov 09, 2022 | Option Exercise | $122.98 | 32,820 | 4,036,155 | 87,721 | Nov 10, 2022, 04:47 PM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Consumer | Nov 07, 2022 | Option Exercise | $109.99 | 17,043 | 1,874,626 | 57,176 | Nov 09, 2022, 05:01 PM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Consumer | Nov 04, 2022 | Sale | $150.97 | 70,492 | 10,642,466 | 75,379 | Nov 08, 2022, 04:59 PM | |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, Chief Information Officer | Nov 02, 2022 | Option Exercise | $172.29 | 3,932 | 677,444 | 7,064 | Nov 04, 2022, 04:30 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 24, 2022 | Sale | $171.36 | 29,275 | 5,016,623 | 143,121 | Oct 26, 2022, 07:21 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 24, 2022 | Sale | $171.19 | 20,851 | 3,569,558 | 164,273 | Oct 26, 2022, 07:21 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 24, 2022 | Sale | $171.22 | 12,998 | 2,225,554 | 177,428 | Oct 26, 2022, 07:20 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 24, 2022 | Sale | $171.14 | 8,256 | 1,412,940 | 187,856 | Oct 26, 2022, 07:20 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 24, 2022 | Sale | $171.13 | 4,263 | 729,520 | 192,819 | Oct 26, 2022, 07:20 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 24, 2022 | Sale | $117.59 | 81,273 | 9,556,666 | 193,134 | Oct 26, 2022, 07:20 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Oct 24, 2022 | Sale | $130.99 | 30,000 | 3,929,820 | 95,236 | Oct 26, 2022, 04:51 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 19, 2022 | Sale | $164.50 | 22,864 | 3,761,197 | 138,840 | Oct 21, 2022, 04:31 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 19, 2022 | Sale | $164.50 | 29,946 | 4,926,207 | 166,686 | Oct 21, 2022, 04:31 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 19, 2022 | Sale | $164.50 | 13,703 | 2,254,185 | 180,983 | Oct 21, 2022, 04:31 PM | |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | Oct 19, 2022 | Sale | $104.94 | 73,739 | 7,738,085 | 184,802 | Oct 21, 2022, 04:31 PM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief GSC Officer | Jun 10, 2022 | Sale | $122.77 | 80,000 | 9,821,640 | 111,311 | Jun 14, 2022, 06:28 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | Controller, CAO | May 26, 2022 | Sale | $126.27 | 16,924 | 2,136,993 | 23,935 | May 31, 2022, 05:21 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Apr 21, 2022 | Sale | $137.01 | 59,398 | 8,138,031 | 109,935 | Apr 25, 2022, 04:33 PM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Consumer | Mar 17, 2022 | Sale | $176.25 | 23,681 | 4,173,718 | 62,394 | Mar 21, 2022, 04:38 PM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Consumer | Mar 17, 2022 | Sale | $120.42 | 41,659 | 5,016,566 | 74,688 | Mar 21, 2022, 04:38 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | Controller, CAO | Mar 15, 2022 | Sale | $124.02 | 10,000 | 1,240,230 | 20,473 | Mar 17, 2022, 04:30 PM | |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | Feb 15, 2022 | Option Exercise | $165.89 | 4,158 | 689,771 | 80,236 | Feb 18, 2022, 07:15 PM | |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | Controller, CAO | Feb 15, 2022 | Option Exercise | $165.89 | 248 | 41,141 | 15,473 | Feb 17, 2022, 06:01 AM | |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 15, 2022 | Option Exercise | $165.89 | 8,841 | 1,466,633 | 126,456 | Feb 17, 2022, 06:01 AM | |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Consumer | Feb 15, 2022 | Option Exercise | $165.89 | 1,843 | 305,735 | 43,903 | Feb 17, 2022, 06:01 AM | |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Feb 15, 2022 | Option Exercise | $165.89 | 7,319 | 1,214,149 | 35,858 | Feb 17, 2022, 06:01 AM | |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief GSC Officer | Feb 15, 2022 | Option Exercise | $165.89 | 4,699 | 779,517 | 71,311 | Feb 17, 2022, 06:01 AM | |
| JNJ | JOHNSON & JOHNSON | McEvoy Ashley | EVP, WW Chair, Medical Devices | Feb 15, 2022 | Option Exercise | $165.89 | 6,242 | 1,035,485 | 41,813 | Feb 17, 2022, 06:01 AM | |
| JNJ | JOHNSON & JOHNSON | Mammen Mathai | EVP, Pharm, R&D | Feb 15, 2022 | Option Exercise | $165.89 | 3,366 | 558,386 | 41,934 | Feb 17, 2022, 06:00 AM |
Menu